Debiopharm International focuses on the development of prescription drugs in oncology and infectious disease. We license and develop promising drug candidates through late stage clinical development at which point commercialization partners are selected in order to maximize patient reach.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    1979
  • Number of employees in Switzerland
    >250